Literature DB >> 11580104

Complex systems analysis: a tool for shock research.

T G Buchman1, J P Cobb, A S Lapedes, T B Kepler.   

Abstract

For the past century, students of shock have focused research efforts to illuminate specific mechanisms that cause, or fail as a consequence of, circulatory collapse. Although clinical strategies aimed at supporting or restoring individual organ systems have proven effective, many patients succumb to more generalized multiple organ system failure. We suggest that general biological systems failure cannot be interpreted through reliance on reductionist science. We propose that complex systems analysis is an essential tool for shock research and we evaluate its application to genomic technologies.

Entities:  

Mesh:

Year:  2001        PMID: 11580104     DOI: 10.1097/00024382-200116040-00002

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  19 in total

Review 1.  Translational systems approaches to the biology of inflammation and healing.

Authors:  Yoram Vodovotz; Gregory Constantine; James Faeder; Qi Mi; Jonathan Rubin; John Bartels; Joydeep Sarkar; Robert H Squires; David O Okonkwo; Jörg Gerlach; Ruben Zamora; Shirley Luckhart; Bard Ermentrout; Gary An
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

2.  In silico and in vivo approach to elucidate the inflammatory complexity of CD14-deficient mice.

Authors:  Jose M Prince; Ryan M Levy; John Bartels; Arie Baratt; John M Kane; Claudio Lagoa; Jonathan Rubin; Judy Day; Joyce Wei; Mitchell P Fink; Sanna M Goyert; Gilles Clermont; Timothy R Billiar; Yoram Vodovotz
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

3.  Evidence-based modeling of critical illness: an initial consensus from the Society for Complexity in Acute Illness.

Authors:  Yoram Vodovotz; Gilles Clermont; C Anthony Hunt; Rolf Lefering; John Bartels; Ruediger Seydel; John Hotchkiss; Shlomo Ta'asan; Edmund Neugebauer; Gary An
Journal:  J Crit Care       Date:  2007-03       Impact factor: 3.425

Review 4.  Translational systems biology: introduction of an engineering approach to the pathophysiology of the burn patient.

Authors:  Gary An; James Faeder; Yoram Vodovotz
Journal:  J Burn Care Res       Date:  2008 Mar-Apr       Impact factor: 1.845

Review 5.  From data patterns to mechanistic models in acute critical illness.

Authors:  Jean-Marie Aerts; Wassim M Haddad; Gary An; Yoram Vodovotz
Journal:  J Crit Care       Date:  2014-03-29       Impact factor: 3.425

6.  Impact of Injury Severity on Dynamic Inflammation Networks Following Blunt Trauma.

Authors:  Khalid Almahmoud; Rami A Namas; Othman Abdul-Malak; Akram M Zaaqoq; Ruben Zamora; Brian S Zuckerbraun; Jason Sperry; Andrew B Peitzman; Timothy R Billiar; Yoram Vodovotz
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

Review 7.  Human movement variability, nonlinear dynamics, and pathology: is there a connection?

Authors:  Nicholas Stergiou; Leslie M Decker
Journal:  Hum Mov Sci       Date:  2011-07-29       Impact factor: 2.161

8.  A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine.

Authors:  Gary Nieman; David Brown; Joydeep Sarkar; Brian Kubiak; Cordelia Ziraldo; Joyeeta Dutta-Moscato; Christopher Vieau; Derek Barclay; Louis Gatto; Kristopher Maier; Gregory Constantine; Timothy R Billiar; Ruben Zamora; Qi Mi; Steve Chang; Yoram Vodovotz
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

9.  Inflammation and Disease: Modelling and Modulation of the Inflammatory Response to Alleviate Critical Illness.

Authors:  Judy D Day; Chase Cockrell; Rami Namas; Ruben Zamora; Gary An; Yoram Vodovotz
Journal:  Curr Opin Syst Biol       Date:  2018-08-23

10.  Reliability of center of pressure measures for assessing the development of sitting postural control.

Authors:  Anastasia Kyvelidou; Regina T Harbourne; Wayne A Stuberg; Junfeng Sun; Nicholas Stergiou
Journal:  Arch Phys Med Rehabil       Date:  2009-07       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.